Comments

Stoke Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Stoke Therapeutics (STOK) operate in?

Stoke Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

STOKNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$7.40

-0.45-5.73%

At close: -

$7.40

0.000.00%

After Hours: 6:29 PM EDT

Stoke Therapeutics (STOK) Forecast

News Earnings Stoke Therapeutics (STOK) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Stoke Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:STOK | Benzinga

Explore Stoke Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for STOK.

Open	$7.84
Close	$7.40
Volume / Avg.	729.67K / 823.71K
Day Range	$7.31 - $7.93
52 Wk Range	5.60 - 17.58
Market Cap	$391.96M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	25
Short Interest	28.43%
Days to Cover	13.06

Recent News

Biogen Strengthens Pipeline With Stoke Therapeutic's Dravet Syndrome Candidate Via Multi-Million Dollar Deal

Biogen and Stoke partner on zorevunersen for Dravet syndrome, with a Phase 3 trial starting in 2025. Stoke gets $165 million upfront and milestone payments.

Vandana Singh

Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$7.84
Close	$7.40
Volume / Avg.	729.67K / 823.71K
Day Range	$7.31 - $7.93
52 Wk Range	5.60 - 17.58
Market Cap	$391.96M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	25
Short Interest	28.43%
Days to Cover	13.06

About Stoke Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregula...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Stoke Therapeutics (STOK) stock?

You can purchase shares of Stoke Therapeutics (NASDAQ:STOK) through any online brokerage.

View our list of the best stock brokerages

Who are Stoke Therapeutics (STOK) competitors?

Other companies in Stoke Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Upstream Bio (NASDAQ:UPB), Sage Therapeutics (NASDAQ:SAGE), PureTech Health (NASDAQ:PRTC) and Emergent BioSolutions (NYSE:EBS).

What is the forecast, or price target, for Stoke Therapeutics (STOK) stock?

Stoke Therapeutics has a consensus price target of $22.25.

What is the current price for Stoke Therapeutics (STOK)?

The stock price for Stoke Therapeutics (NASDAQ: STOK) is $7.4 last updated March 3, 2025 at 6:29 PM EST.

Does Stoke Therapeutics (STOK) pay a dividend?

There are no upcoming dividends for Stoke Therapeutics.

When is Stoke Therapeutics (NASDAQ:STOK) reporting earnings?

Stoke Therapeutics’s Q1 earnings are confirmed for Monday, May 5, 2025.

Is Stoke Therapeutics (STOK) going to split?

There is no upcoming split for Stoke Therapeutics.

What sector and industry does Stoke Therapeutics (STOK) operate in?

Stoke Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.